APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coronary Artery Bypass Grafts (CABG)

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

Selected research

Market Analysis & Forecast

Global Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast 2026-2032

21 December 2025198 pages

Choose your research edition.

Industry ResearchCoronary Artery Bypass Grafts (CABG) Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Coronary Artery Bypass Grafts (CABG) Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Coronary Artery Bypass Grafts (CABG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coronary Artery Bypass Grafts (CABG) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Coronary Artery Bypass Grafts (CABG) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Coronary artery bypass surgery, also known as coronary artery bypass graft (CABG) surgery, and colloquially heart bypass or bypass surgery, is a surgical procedure to restore normal blood flow to an obstructed coronary artery.

Global Coronary Artery Bypass Grafts (CABG) key players include Medtronic, Getinge Group, LivaNova, Terumo, Boston Scientific, etc. Global top five manufacturers hold a share about 65%.

North America is the largest market, with a share over 35%, followed by Europe and Asia-Pacific, both have a share about 55 percent.

Read the full market overview

In terms of product, Saphenous Vein Grafts is the largest segment, with a share about 70%. And in terms of application, the largest application is Traditional CABG, followed by Nontraditional CABG.

Report Includes

This report presents an overview of global market for Coronary Artery Bypass Grafts (CABG), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Coronary Artery Bypass Grafts (CABG), also provides the revenue of main regions and countries. Of the upcoming market potential for Coronary Artery Bypass Grafts (CABG), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Coronary Artery Bypass Grafts (CABG) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Coronary Artery Bypass Grafts (CABG) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Coronary Artery Bypass Grafts (CABG) revenue, projected growth trends, production technology, application and end-user industry.

Coronary Artery Bypass Grafts (CABG) Segment by Company

Medtronic

Getinge Group

LivaNova

Terumo

Boston Scientific

Stryker

Edwards Lifesciences

Genesee Biomedical

Karl Storz GmbH

Coronary Artery Bypass Grafts (CABG) Segment by Type

Saphenous Vein Grafts

Internal Thoracic Artery Grafts

Other

Coronary Artery Bypass Grafts (CABG) Segment by Application

Traditional CABG

Nontraditional CABG

Coronary Artery Bypass Grafts (CABG) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coronary Artery Bypass Grafts (CABG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coronary Artery Bypass Grafts (CABG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coronary Artery Bypass Grafts (CABG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Coronary Artery Bypass Grafts (CABG) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Coronary Artery Bypass Grafts (CABG) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coronary Artery Bypass Grafts (CABG) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Saphenous Vein Grafts Major Player Table 3. Internal Thoracic Artery Grafts Major Player Table 4. Other Major Player Table 5. Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Traditional CABG Major Player Table 7. Nontraditional CABG Major Player Table 8. Coronary Artery Bypass Grafts (CABG) Industry Trends Table 9. Coronary Artery Bypass Grafts (CABG) Industry Drivers Table 10. Coronary Artery Bypass Grafts (CABG) Industry Opportunities and Challenges Table 11. Coronary Artery Bypass Grafts (CABG) Industry Restraints Table 12. Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Coronary Artery Bypass Grafts (CABG) Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Coronary Artery Bypass Grafts (CABG) Market Share by Region (2021-2026) Table 15. Global Coronary Artery Bypass Grafts (CABG) Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Coronary Artery Bypass Grafts (CABG) Market Share by Region (2027-2032) Table 17. Global Coronary Artery Bypass Grafts (CABG) Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Players (2021-2026) Table 19. Global Coronary Artery Bypass Grafts (CABG) Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Coronary Artery Bypass Grafts (CABG) Key Players Headquarters & Area Served Table 21. Global Coronary Artery Bypass Grafts (CABG) Players, Product Type & Application Table 22. Global Coronary Artery Bypass Grafts (CABG) Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Coronary Artery Bypass Grafts (CABG) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Coronary Artery Bypass Grafts (CABG) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2021-2026) Table 29. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2027-2032) Table 30. Global Coronary Artery Bypass Grafts (CABG) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2021-2026) Table 34. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2027-2032) Table 35. Medtronic Company Information Table 36. Medtronic Business Overview Table 37. Medtronic Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Medtronic Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 39. Medtronic Recent Development Table 40. Getinge Group Company Information Table 41. Getinge Group Business Overview Table 42. Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Getinge Group Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 44. Getinge Group Recent Development Table 45. LivaNova Company Information Table 46. LivaNova Business Overview Table 47. LivaNova Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. LivaNova Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 49. LivaNova Recent Development Table 50. Terumo Company Information Table 51. Terumo Business Overview Table 52. Terumo Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Terumo Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 54. Terumo Recent Development Table 55. Boston Scientific Company Information Table 56. Boston Scientific Business Overview Table 57. Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Boston Scientific Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 59. Boston Scientific Recent Development Table 60. Stryker Company Information Table 61. Stryker Business Overview Table 62. Stryker Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Stryker Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 64. Stryker Recent Development Table 65. Edwards Lifesciences Company Information Table 66. Edwards Lifesciences Business Overview Table 67. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 69. Edwards Lifesciences Recent Development Table 70. Genesee Biomedical Company Information Table 71. Genesee Biomedical Business Overview Table 72. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 74. Genesee Biomedical Recent Development Table 75. Karl Storz GmbH Company Information Table 76. Karl Storz GmbH Business Overview Table 77. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Product Portfolio Table 79. Karl Storz GmbH Recent Development Table 80. North America Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Coronary Artery Bypass Grafts (CABG) Revenue by Country (US$ Million) & (2027-2032) Table 87. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021-2026) & (US$ Million) Table 93. Europe Coronary Artery Bypass Grafts (CABG) Revenue by Country (US$ Million) & (2027-2032) Table 94. China Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026) & (US$ Million) Table 95. China Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032) & (US$ Million) Table 96. China Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026) & (US$ Million) Table 97. China Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026) & (US$ Million) Table 99. Asia Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032) & (US$ Million) Table 100. Asia Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026) & (US$ Million) Table 101. Asia Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Coronary Artery Bypass Grafts (CABG) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Coronary Artery Bypass Grafts (CABG) Revenue by Region (US$ Million) & (2021-2026) Table 104. Asia Coronary Artery Bypass Grafts (CABG) Revenue by Region (US$ Million) & (2027-2032) Table 105. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026) & (US$ Million) Table 106. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032) & (US$ Million) Table 107. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026) & (US$ Million) Table 108. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032) & (US$ Million) Table 109. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021-2026) & (US$ Million) Table 111. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Country (US$ Million) & (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Coronary Artery Bypass Grafts (CABG) Image Figure 2. Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coronary Artery Bypass Grafts (CABG) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Saphenous Vein Grafts Image Figure 5. Internal Thoracic Artery Grafts Image Figure 6. Other Image Figure 7. Global Coronary Artery Bypass Grafts (CABG) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Coronary Artery Bypass Grafts (CABG) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Traditional CABG Image Figure 10. Nontraditional CABG Image Figure 11. Global Coronary Artery Bypass Grafts (CABG) Market Size (US$ Million) & (2021-2032) Figure 12. Global Coronary Artery Bypass Grafts (CABG) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Coronary Artery Bypass Grafts (CABG) Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Coronary Artery Bypass Grafts (CABG) Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2021-2032) Figure 19. Global Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2021-2032) Figure 22. North America Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032) Figure 24. North America Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032) Figure 25. North America Coronary Artery Bypass Grafts (CABG) Revenue Share by Country (2021-2032) Figure 26. United States Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032) Figure 31. Europe Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032) Figure 32. Europe Coronary Artery Bypass Grafts (CABG) Revenue Share by Country (2021-2032) Figure 33. Germany Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032) Figure 43. China Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032) Figure 44. Asia Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032) Figure 46. Asia Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032) Figure 47. Asia Coronary Artery Bypass Grafts (CABG) Revenue Share by Region (2021-2032) Figure 48. Japan Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032) Figure 56. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032) Figure 57. SAMEA Coronary Artery Bypass Grafts (CABG) Revenue Share by Country (2021-2032) Figure 58. Brazil Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Coronary Artery Bypass Grafts (CABG) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Saphenous Vein Grafts
  • Internal Thoracic Artery Grafts
  • Other
Applications
  • Traditional CABG
  • Nontraditional CABG
Companies covered
  • Medtronic
  • Getinge Group
  • LivaNova
  • Terumo
  • Boston Scientific
  • Stryker
  • Edwards Lifesciences
  • Genesee Biomedical
  • Karl Storz GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Coronary Artery Bypass Grafts (CABG) Market by Type
  3. 1.2.1 Global Coronary Artery Bypass Grafts (CABG) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Saphenous Vein Grafts
  5. 1.2.3 Internal Thoracic Artery Grafts
  6. 1.2.4 Other
  7. 1.3 Coronary Artery Bypass Grafts (CABG) Market by Application
  8. 1.3.1 Global Coronary Artery Bypass Grafts (CABG) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Traditional CABG
  10. 1.3.3 Nontraditional CABG
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Coronary Artery Bypass Grafts (CABG) Market Dynamics
  1. 2.1 Coronary Artery Bypass Grafts (CABG) Industry Trends
  2. 2.2 Coronary Artery Bypass Grafts (CABG) Industry Drivers
  3. 2.3 Coronary Artery Bypass Grafts (CABG) Industry Opportunities and Challenges
  4. 2.4 Coronary Artery Bypass Grafts (CABG) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Coronary Artery Bypass Grafts (CABG) Market Perspective (2021-2032)
  2. 3.2 Global Coronary Artery Bypass Grafts (CABG) Growth Trends by Region
  3. 3.2.1 Global Coronary Artery Bypass Grafts (CABG) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Coronary Artery Bypass Grafts (CABG) Market Size by Region (2021-2026)
  5. 3.2.3 Global Coronary Artery Bypass Grafts (CABG) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Coronary Artery Bypass Grafts (CABG) Revenue by Players
  2. 4.1.1 Global Coronary Artery Bypass Grafts (CABG) Revenue by Players (2021-2026)
  3. 4.1.2 Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Coronary Artery Bypass Grafts (CABG) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Coronary Artery Bypass Grafts (CABG) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Coronary Artery Bypass Grafts (CABG) Key Players Headquarters & Area Served
  7. 4.4 Global Coronary Artery Bypass Grafts (CABG) Players, Product Type & Application
  8. 4.5 Global Coronary Artery Bypass Grafts (CABG) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Coronary Artery Bypass Grafts (CABG) Market CR5 and HHI
  11. 4.6.3 2025 Coronary Artery Bypass Grafts (CABG) Tier 1, Tier 2, and Tier 3
5 Coronary Artery Bypass Grafts (CABG) Market Size by Type
  1. 5.1 Global Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2032)
  3. 5.3 Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Type (2021-2032)
6 Coronary Artery Bypass Grafts (CABG) Market Size by Application
  1. 6.1 Global Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2032)
  3. 6.3 Global Coronary Artery Bypass Grafts (CABG) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Medtronic
  2. 7.1.1 Medtronic Company Information
  3. 7.1.2 Medtronic Business Overview
  4. 7.1.3 Medtronic Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Medtronic Coronary Artery Bypass Grafts (CABG) Product Portfolio
  6. 7.1.5 Medtronic Recent Developments
  7. 7.2 Getinge Group
  8. 7.2.1 Getinge Group Company Information
  9. 7.2.2 Getinge Group Business Overview
  10. 7.2.3 Getinge Group Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Getinge Group Coronary Artery Bypass Grafts (CABG) Product Portfolio
  12. 7.2.5 Getinge Group Recent Developments
  13. 7.3 LivaNova
  14. 7.3.1 LivaNova Company Information
  15. 7.3.2 LivaNova Business Overview
  16. 7.3.3 LivaNova Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 LivaNova Coronary Artery Bypass Grafts (CABG) Product Portfolio
  18. 7.3.5 LivaNova Recent Developments
  19. 7.4 Terumo
  20. 7.4.1 Terumo Company Information
  21. 7.4.2 Terumo Business Overview
  22. 7.4.3 Terumo Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Terumo Coronary Artery Bypass Grafts (CABG) Product Portfolio
  24. 7.4.5 Terumo Recent Developments
  25. 7.5 Boston Scientific
  26. 7.5.1 Boston Scientific Company Information
  27. 7.5.2 Boston Scientific Business Overview
  28. 7.5.3 Boston Scientific Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Boston Scientific Coronary Artery Bypass Grafts (CABG) Product Portfolio
  30. 7.5.5 Boston Scientific Recent Developments
  31. 7.6 Stryker
  32. 7.6.1 Stryker Company Information
  33. 7.6.2 Stryker Business Overview
  34. 7.6.3 Stryker Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Stryker Coronary Artery Bypass Grafts (CABG) Product Portfolio
  36. 7.6.5 Stryker Recent Developments
  37. 7.7 Edwards Lifesciences
  38. 7.7.1 Edwards Lifesciences Company Information
  39. 7.7.2 Edwards Lifesciences Business Overview
  40. 7.7.3 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Edwards Lifesciences Coronary Artery Bypass Grafts (CABG) Product Portfolio
  42. 7.7.5 Edwards Lifesciences Recent Developments
  43. 7.8 Genesee Biomedical
  44. 7.8.1 Genesee Biomedical Company Information
  45. 7.8.2 Genesee Biomedical Business Overview
  46. 7.8.3 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Genesee Biomedical Coronary Artery Bypass Grafts (CABG) Product Portfolio
  48. 7.8.5 Genesee Biomedical Recent Developments
  49. 7.9 Karl Storz GmbH
  50. 7.9.1 Karl Storz GmbH Company Information
  51. 7.9.2 Karl Storz GmbH Business Overview
  52. 7.9.3 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Karl Storz GmbH Coronary Artery Bypass Grafts (CABG) Product Portfolio
  54. 7.9.5 Karl Storz GmbH Recent Developments
8 North America
  1. 8.1 North America Coronary Artery Bypass Grafts (CABG) Revenue (2021-2032)
  2. 8.2 North America Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2032)
  3. 8.2.1 North America Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026)
  4. 8.2.2 North America Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032)
  5. 8.3 North America Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032)
  6. 8.4 North America Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2032)
  7. 8.4.1 North America Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026)
  8. 8.4.2 North America Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032)
  9. 8.5 North America Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032)
  10. 8.6 North America Coronary Artery Bypass Grafts (CABG) Revenue by Country
  11. 8.6.1 North America Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021-2026)
  13. 8.6.3 North America Coronary Artery Bypass Grafts (CABG) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Coronary Artery Bypass Grafts (CABG) Revenue (2021-2032)
  2. 9.2 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032)
  5. 9.3 Europe Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032)
  9. 9.5 Europe Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Country
  11. 9.6.1 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Coronary Artery Bypass Grafts (CABG) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Coronary Artery Bypass Grafts (CABG) Revenue (2021-2032)
  2. 10.2 China Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2032)
  3. 10.2.1 China Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026)
  4. 10.2.2 China Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032)
  5. 10.3 China Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032)
  6. 10.4 China Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2032)
  7. 10.4.1 China Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026)
  8. 10.4.2 China Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032)
  9. 10.5 China Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Coronary Artery Bypass Grafts (CABG) Revenue (2021-2032)
  2. 11.2 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032)
  5. 11.3 Asia Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032)
  9. 11.5 Asia Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Country
  11. 11.6.1 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Coronary Artery Bypass Grafts (CABG) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue (2021-2032)
  2. 12.2 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Country
  11. 12.6.1 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Coronary Artery Bypass Grafts (CABG) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst